Achieve Life Sciences, Inc. (ACHV)

NASDAQ: ACHV · IEX Real-Time Price · USD

4.630

-0.130 (-2.73%)

At close: Jul 19, 2024, 4:00 PM

4.580

-0.050 (-1.08%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Achieve Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1994
Selling, General & Admin	11.58	11.44	10.72	9.13	7.87	6.85	Upgrade
Research & Development	13.08	15.81	30.08	23.97	6.88	9.67	Upgrade
Operating Expenses	24.65	27.25	40.8	33.09	14.75	16.53	Upgrade
Operating Income	-24.65	-27.25	-40.8	-33.09	-14.75	-16.53	Upgrade
Interest Expense / Income	3.09	2.85	1.79	0	0	0	Upgrade
Other Expense / Income	-0.43	-0.29	-0.24	0.06	-0.02	-0.13	Upgrade
Pretax Income	-27.32	-29.82	-42.35	-33.15	-14.73	-16.4	Upgrade
Net Income	-27.32	-29.82	-42.35	-33.15	-14.73	-16.4	Upgrade
Shares Outstanding (Basic)	25	20	11	8	3	0	Upgrade
Shares Outstanding (Diluted)	25	20	11	8	3	0	Upgrade
Shares Change	39.79%	87.17%	30.46%	198.64%	559.42%	134.93%	Upgrade
EPS (Basic)	-1.27	-1.50	-4.00	-4.08	-5.42	-39.76	Upgrade
EPS (Diluted)	-1.27	-1.50	-4.00	-4.08	-5.42	-39.76	Upgrade
Free Cash Flow	-21.47	-24.5	-37.57	-29.44	-13.49	-15.27	Upgrade
Free Cash Flow Per Share	-0.86	-1.24	-3.55	-3.63	-4.96	-37.03	Upgrade
EBITDA	-24	-26.73	-40.33	-32.9	-14.48	-16.14	Upgrade
Depreciation & Amortization	0.23	0.23	0.24	0.25	0.26	0.25	Upgrade
EBIT	-24.22	-26.96	-40.56	-33.15	-14.73	-16.4	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).